Jose Carlos 'JC' Gutiérrez-Ramos hits the exit at Synlogic; Rich Heyman passes Oric reins to ex-Ignyta CFO
→ An abrupt resignation by president and CEO Jose Carlos Gutiérrez-Ramos has left Synlogic $SYBX in the hands of CMO Aoife Brennan. JC Gutiérrez-Ramos exits the Cambridge biotech almost exactly a year after he orchestrated its reverse merger onto Nasdaq, leaving behind an operation with two ongoing Phase I studies and one discovery pact with AbbVie, all built upon Synlogic’s specialty in reengineering bacteria into therapeutics. No reasons were given for his departure, which comes three years after he joined from Pfizer, where he held a high-profile R&D job. Peter Barrett is stepping into the executive chairman’s role to ensure Brennan can balance her interim executive duties with all the research, preclinical activities and clinical trials underway. Gutiérrez-Ramos” will serve in an advisory capacity as needed.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.